期刊文献+

新诊断的糖代谢异常对急性心肌梗死后左心室射血分数的影响 被引量:3

Effect of newly diagnosed abnormal glycometabolism on left ventricular ejection fraction after acute myocardial infarction
下载PDF
导出
摘要 目的观察新诊断的糖代谢异常对急性心肌梗死后LVEF的影响。方法入选首次急性心肌梗死患者161例(对无糖尿病病史的患者发病7天后行口服葡萄糖耐量试验),根据检查结果及是否有糖尿病病史,分为正常糖耐量组(37例)、糖调节异常组(46例)、新诊断糖尿病组(37例)和既往已确诊糖尿病组(41例)。4组患者分别于发病后72 h内、30天行三维超声心动图检查评价左心室功能。结果糖调节异常组、新诊断糖尿病组和既往已确诊糖尿病组72 h内及30天随访时的LVEF均明显低于正常糖耐量组(72 h:(45.1±7.1)%、(45.0±7.2)%、(45.1±7.2)%vs(48.9±6.8)%,P<0.05;30天:(47.0±7.5)%、(47.8±7.3)%、(48.0±7.4)%vs (53.4±6.4)%,P<0.05]。结论新诊断的糖代谢异常也对急性心肌梗死后左心室功能产生不利的影响。 Objective To investigate the effect of newly diagnosed abnormal glycometabolism on left ventricular ejection fraction(LVEF) after acute myocardial infarction(AMI ). Methods A series of 161 patients with first acute myocardial infarction were enrolled. The patients without diabetes history underwent oral glucose tolerance test(OGTT). The patients were grouped according to glycometabolism status: normal glucose tolerance (n=37), impaired glucose regulation (n = 46 ), newly diagnosed diabetes mellitus (n = 37) and previously known diabetes mellitus (n = 41). Three dimensional echocardiography was performed on admission and 30 days after AMI onset. Results Compared with normal glucose tolerance group, LVEF of impaired glucose regulation, newly diagnosed diabetes mellitus and previously known diabetes mellitus groups were lower on admission and 30 days after AMI onset [on admission:(45.1±7.1)%, (45.0±7.2)%, (45.1±7.2) % vs (48.9+6.8) %, P 〈 0.05 ;30 days after AMI: (47.0±7.5)%, (47.8±7.3)%,(48.0±7.4) % vs (58.4±6.4)%, P 〈 0.05]. Conclusions Abnormal glycometabolism, whether newly diagnosed or previously known,is associated with decreased LVEF after AMI onset.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2009年第2期87-89,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 心肌梗塞 葡萄糖代谢障碍 心室功能 myocardial infarction glucose metabolism disorders ventricular function, left
  • 相关文献

参考文献6

  • 1BartnikM, Ryden L,Ferrari R,et al. The prevalence of abnor mal glucose regulation in patients with coronary artery disease across Europe. the Euro heart survey on diabetes and the heart. Eur Heart J,2004,25:1880-1890.
  • 2Hu DY,Pan CY,Yu JM,et al. The relationship between coro nary artery disease and abnormal glucose regulation in China: the China heart survey. Eur Heart J,2006,27:2573-2579.
  • 3Fazel R, Fang J, Rogers EK, et al. Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes. Heart, 2005,91 : 388-390.
  • 4Schramm TK,Gunnar H,Kφber L,et al. Diabetes patients re quiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk. Circulation, 2008,117 : 1945-1954.
  • 5Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortality following acute coronary syndromes. JAMA, 2007, 298:765-775.
  • 6Tamita K, Katayama M, Takagi T, et al. Impact of newly diag nosed abnormal glucose tolerance on long term prognosis in patients with acute myocardial infarction. Circ J, 2007,71 : 834- 841.

同被引文献38

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3055
  • 2胡荣,聂绍平,杜昕,吕强,康俊萍,张崟,梁金鑫,郝鹏,王苏,刘彤,吴学思,董建增,刘晓惠,马长生.代谢综合征在非ST段抬高急性冠脉综合征患者中的临床特点及近期预后[J].中华急诊医学杂志,2006,15(6):529-532. 被引量:7
  • 3Fazel R, Fang J, Kline-Rogers E, et al. Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes. Heart, 2005,91:388-390.
  • 4Hu DY,Pan CY, Yu JM. China Heart Survey Group. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J, 2006, 27:2573-2579.
  • 5UK Prospective Diabetes Study ( UKPDS ) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ( UKPDS 33 ). Lancet, 1998,352:837-853.
  • 6Holman RR,Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008,359 : 1577-1589.
  • 7Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med, 2008,358:2545-2559.
  • 8Caracciolo EA, Chaitman BR, Forman SA, et al. Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. An ACIP database study. ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot Investigators. Circulation, 1996,93:2097-2105.
  • 9Klamann A, Sarfert P, Launhardt V, et al. Myocardial infarction in diabetic vs. non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas ( glibenclamide ). Eur Heart J, 2000,21 : 220 -229.
  • 10Gazzaruso C,Solerte SB,De Amici E,et al. Association of the me?tabolism syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus[J].Am J Cardiol,2006,97(2):236-239.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部